Imperial Oil Limited Common Stock vs Revvity Inc — how do they compare? Imperial Oil Limited Common Stock trades at $130.2 (market cap $62.22B), while Revvity Inc trades at $153 (market cap $17.30B). The key difference: Imperial Oil Limited Common Stock is far larger — about 3.6× Revvity Inc's market cap, and Imperial Oil Limited Common Stock pays the higher dividend (1.9%). Which is the better fit depends on your goals.
| IMO | RVTY | |
|---|---|---|
Market Cap | $62.22B | $17.30B |
Volume | 560,544 | 1,387,588 |
Sector | Energy | Health |
52-Week High | $138.33 | $157.36 |
52-Week Low | $83.72 | $82.26 |
Enterprise Value | $63.13B | $19.62B |
Dividend Yield | 1.9% | 0.18% |
Typical Hold Time | — | 13 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RVTY trades at $155.08, down 0.34% on the day but near its 52-week high of $158.28. The stock shows strong technical momentum with bullish moving averages and has consistently beaten earnings estimates in recent quarters. Recent developments include the launch of a new diabetes detection kit in Europe and the acquisition of Human Cell Design to expand metabolic disease research capabilities. The company maintains solid profitability with 54.98% gross margins and positive cash flow trends.
RVTY presents growth potential through diagnostic expansion and AI-driven demand, though premium valuation metrics (P/E 74.56) require careful consideration. Near-term catalysts include Q3 earnings on November 3, 2026, while risks involve China market pressures and margin compression. Analyst consensus leans bullish with 52% buy ratings and a $132.13 price target, suggesting potential downside from current levels despite positive momentum.
Trailing returns across standard periods
Imperial Oil Limited is a Canadian integrated energy company that explores for and produces crude oil and natural gas, operates oil sands projects at Cold Lake, Kearl, and Syncrude, and refines and markets petroleum products under the Esso and Mobil brands. ExxonMobil Corporation holds a majority ownership stake in the company.
Read more on IMO →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →